Polygon Summer Game Fest 2026 Live game reveals, world premiere trailers, and what’s next from 40+ developers, publishers, and hardware makers. The trailer shows Claire Redfield entering a run-down ...

Mida chairman Tengku Datuk Seri Zafrul Abdul Aziz. KUALA LUMPUR: The misconception that data centres (DCs) only generate jobs is misplaced as they bring about wider economic benefits beyond direct ...

WASHINGTON, June 4 (Reuters) - Commonwealth Fusion Systems, the world's top-funded private firm among those seeking to generate power by replicating the nuclear reaction that takes place in stars, ...

Google on Tuesday unveiled a new “Create My Widget” feature for Android that allows users to vibe-code their own custom widgets. The feature will first launch on the latest Samsung Galaxy and Google ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Anyone can code using AI. But it might come with a hidden cost. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading. Over the past year, AI systems ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Fans were gripping fences all Sunday morning as the sounds of racecars serenaded the tens of thousands who flocked to IndyCar’s inaugural Java House Grand Prix of Arlington. Kyle Kirkwood won the race ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...